Peripheral and Biliary Stents Healthcare Professionals

Deliver the same, trusted Protégé™ EverFlex™ stent with the ease of single handed deployment when choosing the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system to treat PAD in the SFA, proximal popliteal, subclavian, and common or external iliac arteries. The system's low profile (5Fr), triaxial design reduces friction during deployment, which allows for increased accuracy and more predictable stent placement. The system is available in 150cm shaft lengths for situations where extended reach is needed.

Choose the Protégé™ EverFlex™ self-expanding peripheral stent system for its combined benefits of durability and deployment accuracy — all in a broad range of sizes. Treat lesions in either the SFA, proximal popliteal, subclavian, common and/or external iliac arteries or in the biliary system with confidence, knowing that the DURABILITY trial series demonstrated safety and efficacy of the EverFlex stent in complex patient populations.

Select the Protégé™ GPS™ self-expanding peripheral stent system when your work depends on precision, radial strength and flexibility in treating lesions in the common or external iliac arteries, subclavian arteries or in the biliary system.

Select the Protégé™ RX GPS™ self-expanding peripheral and carotid stent system, in straight or tapered models, for custom fit in the common iliac, external iliac, subclavian, common carotid, or internal carotid arteries, and carotid bifurcation when stenting procedures are indicated. Tantalum GPS markers enhance visibility for precise positioning and result confirmation.

Ensure visibility before and after stent placement with the Visi-Pro™ balloon-expandable peripheral stent system for treatment of peripheral arterial disease (PAD). The stent's patented design balances strength and flexibility for proven patency as found in the VISIBILITY ILIAC study. Radiopaque markers on the stent ensure precise placement. Deliver over an 0.035" guidewire for use in the common iliac, external iliac, and subclavian arteries as in also indicated for palliative treatment of malignant neoplasms in the biliary tree.

Treat the renal artery with the stent designed specifically for renal artery angioplasty, the Hippocampus™ renal RX stent system. Available on an 0.014" platform, the stent offers precise ostial placement, ostial scaffolding, enhanced pushability, and progressive flexibility on the distal balloon segment. Access the renal artery via a femoral, axiliar, brachial, or radial approach with an 80 or 145 cm long catheter shaft. Available in stent diameters from 4 to 7 mm, and stent lengths from 10 to 24 mm.

Need to choose an unmounted stent in varying degrees of flexibility, strength and coverage to accommodate the unique needs of your patient? The IntraStent™ DoubleStrut™ LD stent is your best choice for flexibility within the IntraStent family. The stent is indicated for use in occlusions, lesions at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (PTA) or lesions believed to be at high risk of restenosis following PTA in the common iliac, external iliac, or subclavian arteries. The stent is also intended as a palliative treatment of malignant neoplasms
in the biliary tree.

Need to choose an unmounted stent in varying degrees of flexibility, strength and coverage to accommodate the unique needs of your patient? The IntraStent™ Mega™ LD stent offers the best balance of strength and flexibility within the IntraStent™ family. The stent is indicated for use in occlusions, lesions at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (PTA) or lesions believed to be at high risk of restenosis following PTA in the common iliac, external iliac, or subclavian arteries. The stent is also intended as a palliative treatment of malignant
neoplasms in the biliary tree.

Need to choose an unmounted stent in varying degrees of flexibility, strength and coverage to accommodate the unique needs of your patient? The IntraStent™ Max™ LD stent is your best choice for strength within the IntraStent™ family. The stent is indicated for use in occlusions, lesions at high risk for abrupt closure or threatened closure following percutaneous transluminal angioplasty (PTA) or lesions believed to be at high risk of restenosis following PTA in the common iliac, external iliac, or subclavian arteries. The stent is also intended as a palliative treatment of malignant neoplasms in the biliary tree.